While STEAP3 was unrelated to any improvement in overall breast cancer patient OS, other studies have found a relationship between downregulation of the related STEAP1, STEAP2, and STEAP4 proteins and improved outcomes (37). This evidence concerns the gene STEAP2 and breast cancer.